Decorin mimic inhibits vascular smooth muscle proliferation and migration

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Scott, Rebecca A ^a   Paderi, John E ^a   Sturek, Michael ^b   Panitch, Alyssa ^a  

^a PURDUE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; DECORIN; DERMATAN SULFATE COLLAGEN BINDING PEPTIDE TYPE 1; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; THROMBOMODULIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME RELEASE; HUMAN; HUMAN CELL; HYPERPLASIA; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OSSABAW MINIATURE SWINE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RESTENOSIS; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; VASCULAR SMOOTH MUSCLE;

CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DECORIN; HUMANS; MOLECULAR MIMICRY; MUSCLE, SMOOTH, VASCULAR; PLATELET ACTIVATION; THROMBOMODULIN; TUNICA INTIMA;

EID: 84896731108     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082456     Document Type: Article

References (48)

1. Buie VC, Owings MF, DeFrances CJ, Golosinskiy A (2010) National Hospital Discharge Survey: 2006 Summary. National Center for Health Statistics.
2. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB et al. (2008) Heart Disease and Stroke Statistics - 2009 Update. A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119: 1-161.
3. Association AH (2010) Heart Disease and Stroke Statistics - 2010 Update. Dallas, Texas: American Heart Association.
4. Farndale RW (2006) Collagen-induced platelet activation. Blood Cells Mol Dis 36: 162-165. doi:10.1016/j.bcmd.2005.12.016. PubMed: 16464621.
5. Roberts DE, McNicol A, Bose R (2004) Mechanism of Collagen Activation in Human Platlets. J Biol Chem 279: 19421-19430. doi:10.1074/jbc.M308864200. PubMed: 14981087. (Pubitemid 38623375)
6. Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD et al. (1999) Pathology of Acute and Chronic Coronary Stenting in Humans. Circulation 99: 44-52. doi:10.1161/01.CIR.99.1.44. PubMed: 9884378. (Pubitemid 29035956)
7. Ip JH, Fuster V, Israel D, Badimon L, Chesebro J (1991) The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol 17: 77-88B. doi:10.1016/0735-1097(91)91273-H. PubMed: 2016486.
8. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V et al. (1994) Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 90: 775-778. doi:10.1161/01.CIR.90.2.775. PubMed: 8044947. (Pubitemid 24242744)
9. Loppnow H, Bil R, Hirt S, Schönbeck U, Herzberg M et al. (1998) Platelet-Derived Interleukin-1 Induces Cytokine Production, but not Proliferation of Human Vascular Smooth Muscle Cells. Blood 91: 134-141. PubMed: 9414277. (Pubitemid 28018737)
10. Amento EP, Ehsani N, Palmer H, Libby P (1991) Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 11: 1223-1230. doi:10.1161/01.ATV.11.5.1223. PubMed: 1911708.
11. Karas SP, Gravanis MB, Santoian EC, Robinson KA, Anderberg KA et al. (1992) Coronary intimal proliferation after balloon injury and stenting in swing: An animal model of restenosis. J Am Coll Cardiol 20: 467-474. doi:10.1016/0735-1097(92)90119-8. PubMed: 1634687.
12. Hanke H, Strohschneider T, Oberhoff M, Betz E, Karsch KR (1990) Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ Res 67: 651-659. doi:10.1161/01.RES.67. 3.651. PubMed: 1697794. (Pubitemid 20314992)
13. MacLeod DC, Strauss BH, de Jong M, Escaned J, Umans VA et al. (1994) Proliferation and extracellular matrix synthesis of smooth muscle cells cultured from human coronary atherosclerotic and restenotic lesions. J Am Coll Cardiol 23: 59-65. doi:10.1016/0735-1097(94)90502-9. PubMed: 8277096. (Pubitemid 24027192)
14. Rekhter MD (1999) Collagen synthesis in atherosclerosis: too much and not enough. Cardiovasc Res 41: 376-384. doi:10.1016/S0008-6363(98)00321-6. PubMed: 10341837.
15. Regar E, Sianos G, Serruys PW (2001) Stent development and local drug delivery. Br Med Bull 59: 227-248. doi:10.1093/bmb/59.1.227. PubMed: 11756213. (Pubitemid 34076026)
16. van der Hoeven BL, Pires NMM, Warda HM, Oemrawsingh PV, van Vlijmen BJM et al. (2005) Drug-eluting stents: results, promises and problems. Int J Cardiol 99: 9-17. doi:10.1016/j.ijcard.2004.01.021. PubMed: 15721493. (Pubitemid 40261018)
17. Azrin MA, Mitchel JF, Fram DB, Pedersen CA, Cartun RW et al. (1994) Decreased platelet deposition and smooth muscle cell proliferation after intramural heparin delivery with hydrogel-coated balloons. Circulation 90: 433-441. doi:10.1161/01.CIR.90.1.433. PubMed: 8026030. (Pubitemid 24203709)
18. Garcia-Touchard A, Burke SE, Toner JL, Cromack K, Schwartz RS (2006) Zotarolimus-eluting stents reduce experimental coronary artery neointimal hyperplasia after 4 weeks. Eur Heart J 27: 988-993. PubMed: 16449248.
19. Matter CM, Rozenberg I, Jaschko A, Greutert H, Kurz DJ et al. (2006) Effects of Tacrolimus or Sirolimus on Proliferation of Vascular Smooth Muscle and Endothelial Cells. J Cardiovasc Pharmacol 48: 286-292. doi:10.1097/01.fjc. 0000248233.22570.8b. PubMed: 17204907. (Pubitemid 46066833)
20. Joner M, Nakazawa G, Finn AV, Quee SC, Coleman L et al. (2008) Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents. J Am Coll Cardiol 52: 333-342. doi:10.1016/j.jacc.2008.04.030. PubMed: 18652940. (Pubitemid 352001347)
21. Riessen R, Isner JM, Blessing E, Loushin C, Nikol S et al. (1994) Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol 144: 962-974. PubMed: 8178945. (Pubitemid 24160637)
22. Salisbury BG, Wagner WD (1981) Isolation and preliminary characterization of proteoglycans dissociatively extracted from human aorta. J Biol Chem 256: 8050-8057. PubMed: 7263639. (Pubitemid 12229842)
23. Nili N, Cheema AN, Giordano FJ, Barolet AW, Babaei S et al. (2003) Decorin Inhibition of PDGF-Stimulated Vascular Smooth Muscle Cell Function: Potential Mechanism for Inhibition of Intimal Hyperplasia after Balloon Angioplasty. Am J Pathol 163: 869-878. doi:10.1016/S0002-9440(10)63447-5. PubMed: 12937128. (Pubitemid 37040123)
24. Davies CdL, Melder RJ, Munn LL, Mouta-Carreira C, Jain RK et al. (2001) Decorin Inhibits Endothelial Migration and Tube-like Structure Formation: Role of Thrombospondin-1. Microvasc Res 62: 26-42. doi:10.1006/mvre.2001.2311. PubMed: 11421658. (Pubitemid 32679304)
25. Fiedler LR, Schönherr E, Waddington R, Niland S, Seidler DG et al. (2008) Decorin Regulates Endothelial Cell Motility on Collagen I through Activation of Insulin-like Growth Factor I Receptor and Modulation of a2b1 Integrin Activity. J Biol Chem 283: 17406-17415. doi:10.1074/jbc.M710025200. PubMed: 18413316.
26. Fiedler LR, Eble JA (2009) Decorin regulates endothelial cell-matrix interactions during angiogenesis. Cell Adh Migr 3: 3-6. doi:10.4161/cam.3.1. 7275. PubMed: 19372733.
27. D'Antoni ML, Torregiani C, Ferraro P, Michoud MC, Mazer B et al. (2008) Effects of decorin and biglycan on human airway smooth muscle cell proliferation and apoptosis. Am J Physiol Lung Cell Mol Physiol 294: L764-L771. doi:10.1152/ajplung.00436.2007. PubMed: 18245265. (Pubitemid 351520110)
28. Zafiropoulos A, Nikitovic D, Katonis P, Tsatsakis A, Karamanos NK et al. (2008) Decorin-Induced Growth Inhibition Is Overcome through Protracted Expression and Activation of Epidermal Growth Factor Receptors in Osteosarcoma Cells. Mol Cancer Res 6: 785-794. doi:10.1158/1541-7786.MCR-07-0165. PubMed: 18505923.
29. Paderi JE, Panitch A (2008) Design of a Synthetic Collagen-Binding Peptidoglycan that Modulates Collagen Fibrillogenesis. Biomacromolecules 9: 2562-2566. doi:10.1021/bm8006852. PubMed: 18680341.
30. Paderi JE, Stuart K, Sturek M, Park K, Panitch A (2011) The inhibition of platelet adhesion and activation on collagen during balloon angioplasty by collagen-binding peptidoglycans. Biomaterials 32: 2516-2523. doi:10.1016/j.biomaterials.2010.12.025. PubMed: 21216002.
31. Chaterji S, Park K, Panitch A (2010) Scaffold-Free In Vitro Arterial Mimetics: The Importance of Smooth Muscle-Endothelium Contact. Tissue Eng Part A 16: 1901-1912. doi:10.1089/ten.tea.2009.0271. PubMed: 20088699.
32. Beatty KE, Liu JC, Xie F, Dieterich DC, Schuman EM et al. (2006) Fluorescence Visualization of Newly Synthesized Proteins in Mammalian Cells. Angew Chem Int Ed Engl 45: 7364-7367. doi:10.1002/anie.200602114. PubMed: 17036290. (Pubitemid 44786958)
33. Edwards JM, Neeb ZP, Alloosh MA, Long X, Bratz IN et al. (2010) Exercise training decreases store-operated Ca2+entry associated with metabolic syndrome and coronary atherosclerosis. Cardiovasc Res 85: 631-640. doi:10.1093/cvr/ cvp308. PubMed: 19744946.
34. Long X, Bratz IN, Alloosh M, Edwards JM, Sturek M (2010) Short-term exercise training prevents micro- and macrovascular disease following coronary stenting. J Appl Physiol (1985) 108: 1766-1774. doi:10.1152/japplphysiol.01014. 2009. PubMed: 20299615.
35. Sturek M, Wenzel J, Byrd JP, Edwards JM, Lloyd P et al. (2007) Ossabaw Island miniature swine: cardiometabolic syndrome assessment. In: M Swindle. Swine in the laboratory: surgery, anesthesia, imaging, and experimental techniques. Boca Raton: CRC Press. pp. 397-402.
36. Boyden S (1962) The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med 115: 453-466. doi:10.1084/jem.115.3.453. PubMed: 13872176.
37. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K et al. (1988) Restenosis After Successful Percutaneous Transluminal Coronary Angioplasty: Serial Angiographic Follow-Up of 229 Patients. J Am Coll Cardiol 12: 616-623. doi:10.1016/S0735-1097(88)80046-9. PubMed: 2969925.
38. Majack RA, Clowes AW (1984) Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J Cell Physiol 118: 253-256. doi:10.1002/jcp.1041180306. PubMed: 6699099. (Pubitemid 14162993)
39. Nobuyoshi M, Kimura T, Ohishi H, Horiuchi H, Nosaka H et al. (1991) Restenosis after percutaneous transluminal coronary angioplasty: Pathologic observations in 20 patients. J Am Coll Cardiol 17: 433-439. doi:10.1016/S0735- 1097(10)80111-1. PubMed: 1991900.
40. Belmiro CLR, Gonçalves RG, Kozlowski EO, Werneck AF, Takyia CM et al. (2011) Dermatan sulfate reduces monocyte chemoattractant protein 1 and TGF-≤ production, as well as macrophage recruitment and myofibroblast accumulation in mice with unilateral ureteral obstruction. Brazilian Journal of Medical and Biological Research 44: 624-633. doi:10.1590/S0100- 879X2011000700003. PubMed: 21833458.
41. Sukkar MB, Stanley AJ, Blake AE, Hodgkin PD, Johnson PRA et al. (2004) 'Proliferative' and 'synthetic' airway smooth muscle cells are overlapping populations. Immunol Cell Biol 82: 471-478. doi:10.1111/j.0818-9641.2004.01275. x. PubMed: 15479432. (Pubitemid 39421056)
42. Rectenwald JE, Moldawer LL, Huber TS, Seeger JM, Ozaki CK (2000) Direct Evidence for Cytokine Involvement in Neointimal Hyperplasia. Circulation 102: 1697-1702. doi:10.1161/01.CIR.102.14.1697. PubMed: 11015350.
43. Sanchez-Guerrero E, Chen E, Kockx M, An S-W, Chong BH et al. (2012) IL-1beta Signals through the EGF Receptor and Activates Egr-1 through MMP-ADAM. PLOS ONE 7: e39811. doi:10.1371/journal.pone.0039811. PubMed: 22792188.
44. Wen DZ, Dittman WA, Ye RD, Deaven LL, Majerus PW et al. (1987) Human thrombomodulin: complete cDNA sequence and chromosome localization of the gene. Biochemistry 26: 4350-4357. doi:10.1021/bi00388a025. PubMed: 2822087. (Pubitemid 17137065)
45. Lo IC, Lin TM, Chou LH, Liu SL, Wu LW et al. (2009) Ets-1 mediates platelet-derived growth factor-BB-induced thrombomodulin expression in human vascular smooth muscle cells. Cardiovasc Res 81: 771-779. PubMed: 19091791.
46. Waugh JM, Li-Hawkins J, Yuksel E, Kuo MD, Cifra PN et al. (2000) Thrombomodulin Overexpression to Limit Neointima Formation. Circulation 102: 332-337. doi:10.1161/01.CIR.102.3.332. PubMed: 10899098. (Pubitemid 30457585)
47. Li JM, Singh MJ, Itani M, Vasiliu C, Hendricks G et al. (2004) Recombinant human thrombomodulin inhibits arterial neointimal hyperplasia after balloon injury. J Vasc Surg 39: 1074-1083. doi:10.1016/j.jvs.2003.12.030. PubMed: 15111864. (Pubitemid 38581640)
48. Loftus JC, Choate J, Albrecht RM (1984) Platelet activation and cytoskeletal reorganization: high voltage electron microscopic examination of intact and Triton-extracted whole mounts. J Cell Biol 98: 2019-2025. doi:10.1083/jcb.98.6.2019. PubMed: 6539337. (Pubitemid 14121833)